Stem cells: Balancing resistance and sensitivity to DNA damage

Trends in Cell Biology

Volumn 24, Issue 5, 2014, Pages 268-274

  Liu, Julia C ^a   Lerou, Paul H ^b   Lahav, Galit ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apoptosis; HESCs; Mitochondrial priming; P53

Indexed keywords

ADULT STEM CELL; ANIMAL; APOPTOSIS; CANCER STEM CELL; DNA DAMAGE; EMBRYONIC STEM CELL; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; RADIATION DOSE; RADIATION RESPONSE;

ADULT STEM CELLS; ANIMALS; APOPTOSIS; DNA DAMAGE; EMBRYONIC STEM CELLS; HUMANS; MITOCHONDRIA; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE;

EID: 84899490238     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.03.002     Document Type: Review

References (59)

1. Horsfall F.L. Current concepts of cancer. Can. Med. Assoc. J. 1963, 89:1224-1229.
2. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
3. Gudkov A.V., Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 2003, 3:117-129.
4. Qin H., et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 2006, 282:5842-5852.
5. Grandela C., et al. p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Res. 2008, 1:116-128.
6. Filion T.M., et al. Survival responses of human embryonic stem cells to DNA damage. J. Cell. Physiol. 2009, 220:586-592.
7. Hong Y., Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:14443-14448.
8. Solozobova V., et al. Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol. 2009, 10:46.
9. Mandal P.K., et al. DNA damage response in adult stem cells: pathways and consequences. Nat. Rev. Mol. Cell Biol. 2011, 12:198-202.
10. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
11. Batchelor E., et al. Stimulus-dependent dynamics of p53 in single cells. Mol. Syst. Biol. 2011, 7:488.
12. Riley T., et al. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
13. Hande K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 1998, 34:1514-1521.
14. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
15. Dumitru R., et al. Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Mol. Cell 2012, 46:573-583.
16. Liu J.C., et al. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell 2013, 13:483-491.
17. Ni Chonghaile T., et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011, 334:1129-1133.
18. Madden D.T., et al. Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members. PLoS ONE 2011, 6:e28530.
19. Becker K.A., et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 2006, 209:883-893.
20. Filipczyk A.A., et al. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res. 2007, 1:45-60.
21. Neganova I., et al. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009, 28:20-30.
22. Zhang X., et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J. Cell Biol. 2009, 184:67-82.
23. Lewis M.R., Lewis W.H. Mitochondria in tissue culture. Science 1914, 39:330-333.
24. Bereiter-Hahn J., Voth M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc. Res. Tech. 1994, 27:198-219.
25. Mitra K. Mitochondrial fission-fusion as an emerging key regulator of cell proliferation and differentiation. Bioessays 2013, 35:955-964.
26. Mitra K., et al. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11960-11965.
27. Facucho-Oliveira J.M., St.John J.C. The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Rev. 2009, 5:140-158.
28. Prigione A., et al. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28:721-733.
29. Varum S., et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE 2011, 6:e20914.
30. Vazquez-Martin A., et al. Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness. Aging 2012, 4:393-401.
31. Karbowski M., Youle R.J. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 2003, 10:870-880.
32. Mohrin M., et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010, 7:174-185.
33. Insinga A., et al. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:3931-3936.
34. Rachidi W., et al. Sensing radiosensitivity of human epidermal stem cells. Radiother. Oncol. 2007, 83:267-276.
35. Qiu W. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008, 2:576-583.
36. Purvis J.E., et al. p53 dynamics control cell fate. Science 2012, 336:1440-1444.
37. Sotiropoulou P.A., et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat. Cell Biol. 2010, 12:572-582.
38. Merritt A.J., et al. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell Sci. 1995, 108:2261-2271.
39. Cheung T.H., Rando T.A. Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 2013, 14:329-340.
40. Savatier P., et al. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 1994, 9:809-818.
41. Milyavsky M., et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 2010, 7:186-197.
42. Blanpain C., et al. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 2011, 8:16-29.
43. Rossi D.J., et al. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007, 6:2371-2376.
44. Kenyon J., Gerson S.L. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2007, 35:7557-7565.
45. Vo T-T., et al. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 2012, 151:344-355.
46. Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007, 35:495-516.
47. Dewson G., Kluck R.M. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell Sci. 2009, 122:2801-2808.
48. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
49. Huang D.C., Strasser A. BH3-only proteins - essential initiators of apoptotic cell death. Cell 2000, 103:839-842.
50. Taylor R.C., et al. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
51. Oda E., et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
52. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010, 20:14-24.
53. Mihara M., et al. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
54. Tomita Y., et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 2006, 281:8600-8606.
55. Chipuk J.E., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
56. Chipuk J.E., et al. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309:1732-1735.
57. Leu J.I-J., et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 2004, 6:443-450.
58. Pietsch E.C., et al. The tetramerization domain of p53 is required for efficient BAK oligomerization. Cancer Biol. Ther. 2007, 6:1576-1583.
59. Han J., et al. Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim. J. Biol. Chem. 2010, 285:22473-22483.